Literature DB >> 27832936

Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry.

Kiran V Sandhu1, Eoin Sherwin1, Harriët Schellekens2, Catherine Stanton3, Timothy G Dinan4, John F Cryan5.   

Abstract

The microbial population residing within the human gut represents one of the most densely populated microbial niche in the human body with growing evidence showing it playing a key role in the regulation of behavior and brain function. The bidirectional communication between the gut microbiota and the brain, the microbiota-gut-brain axis, occurs through various pathways including the vagus nerve, the immune system, neuroendocrine pathways, and bacteria-derived metabolites. This axis has been shown to influence neurotransmission and the behavior that are often associated with neuropsychiatric conditions. Therefore, research targeting the modulation of this gut microbiota as a novel therapy for the treatment of various neuropsychiatric conditions is gaining interest. Numerous factors have been highlighted to influence gut microbiota composition, including genetics, health status, mode of birth, and environment. However, it is diet composition and nutritional status that has repeatedly been shown to be one of the most critical modifiable factors regulating the gut microbiota at different time points across the lifespan and under various health conditions. Thus the microbiota is poised to play a key role in nutritional interventions for maintaining brain health.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27832936     DOI: 10.1016/j.trsl.2016.10.002

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  125 in total

Review 1.  Interactions between host and gut microbiota in domestic pigs: a review.

Authors:  Yadnyavalkya Patil; Ravi Gooneratne; Xiang-Hong Ju
Journal:  Gut Microbes       Date:  2019-11-24

2.  Introduction to the special focus issue on the impact of diet on gut microbiota composition and function and future opportunities for nutritional modulation of the gut microbiome to improve human health.

Authors:  Sharon M Donovan
Journal:  Gut Microbes       Date:  2017-02-28

Review 3.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

Review 4.  Environmental Exposures and Neuropsychiatric Disorders: What Role Does the Gut-Immune-Brain Axis Play?

Authors:  Shannon Delaney; Mady Hornig
Journal:  Curr Environ Health Rep       Date:  2018-03

Review 5.  Vagal Interoceptive Modulation of Motivated Behavior.

Authors:  J W Maniscalco; L Rinaman
Journal:  Physiology (Bethesda)       Date:  2018-03-01

Review 6.  Butyrate: A Double-Edged Sword for Health?

Authors:  Hu Liu; Ji Wang; Ting He; Sage Becker; Guolong Zhang; Defa Li; Xi Ma
Journal:  Adv Nutr       Date:  2018-01-01       Impact factor: 8.701

Review 7.  Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders.

Authors:  Amir Abdoli; Hoda Mirzaian Ardakani
Journal:  Metab Brain Dis       Date:  2019-07-27       Impact factor: 3.584

8.  The ENGAGE-2 study: Engaging self-regulation targets to understand the mechanisms of behavior change and improve mood and weight outcomes in a randomized controlled trial (Phase 2).

Authors:  Nan Lv; Olusola A Ajilore; Corina R Ronneberg; Elizabeth M Venditti; Mark B Snowden; Philip W Lavori; Lan Xiao; Andrea N Goldstein-Piekarski; Joseph Wielgosz; Nancy E Wittels; Amruta Barve; Aashutos S Patel; Tessa L Eckley; Patrick Stetz; Ben S Gerber; Joshua M Smyth; Janine M Simmons; Lisa G Rosas; Leanne M Williams; Jun Ma
Journal:  Contemp Clin Trials       Date:  2020-07-02       Impact factor: 2.226

Review 9.  System biology approach intersecting diet and cell metabolism with pathogenesis of brain disorders.

Authors:  Fernando Gomez-Pinilla; Xia Yang
Journal:  Prog Neurobiol       Date:  2018-07-27       Impact factor: 11.685

10.  Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats.

Authors:  Chao Luo; Xu Wang; Han-Xue Huang; Xiao-Yuan Mao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Psychopharmacology (Berl)       Date:  2020-10-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.